Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
Goodfellow Gems #55
Goodfellow Gems #55
Wednesday 10 May 2017, 02:53 PM
Beta-blockers no longer first line for simple hypertension
Initiating treatment of hypertension with beta-blockers leads to modest CVD reductions and little or no effects on mortality (atenolol mainly studied)
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
1. Wiysonge CS, et al. Beta-blockers for hypertension. Cochrane Database Syst Rev. 2017 http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD002003.pub5/abstract;jsessionid=34B9346C6964ECB39CF395D4C5441945.f04t03
2. New Zealand Primary Care handbook 2012, p37 \http://www.health.govt.nz/publication/new-zealand-primary-care-handbook-2012
3. Medsafe Datasheet 2014. http://www.medsafe.govt.nz/profs/Datasheet/b/bosvatetab.pdf